Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01328015Phase 2Completed
A Phase 2 trial of oxybutynin, sponsored by Federal University of São Paulo. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01328015.